MANUFACTURING TECHNOLOGY

Atara Biotherapeutics and Fujifilm Form Strategic Manufacturing Partnership

Atara | January 27, 2022

Atara Biotherapeutics and Fujifilm
On January 26, Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy, announced that it has entered into a long-term strategic agreement with FUJIFILM Diosynth Biotechnologies (FDB), a subsidiary of FUJIFILM Corporation (Fujifilm), under which Fujifilm will acquire Atara's T-Cell Operations and Manufacturing (ATOM).

A long-term supply agreement, possibly lasting ten years, will also be signed by the parties. Following the completion of the transaction, FDB, a leading contract development, and manufacturing organization (CDMO) focused on advanced therapies, will provide Atara with access to the flexible capacity and specialized capability necessary to manufacture clinical-and commercial-stage allogeneic cell therapies for its maturing and promising pipeline, including tabelecleucel (tab-cel®), which is currently undergoing regulatory review in Europe for EBV+ PTLD, ATA188 for multiple sclerosis, and allogeneic CAR T. Additionally, FDB will increase its reliance on the Thousand Oaks facility and harness its experienced workforce to manufacture a broader array of cell therapies. Atara will retain its manufacturing process science expertise, personnel, and capabilities to continue developing the initial manufacturing and scale-up of allogeneic cell treatments.

"FUJIFILM Diosynth Biotechnologies is a highly respected, quality-focused, industry-leading manufacturing and development organization that shares our pioneering culture and belief that allogeneic cell therapies will transform the future of medicine, We are incredibly proud of our world-class ATOM staff and facility and believe that this strategic partnership will meet our long-term manufacturing needs. Our team has developed processes for our products, scaled them up, and built inventory for clinical trials and the potential commercial launch of tab-cel. We believe that now is the right time for a strategic relationship with FDB to provide us with expert manufacturing capabilities, as needed. Accordingly, we will further focus our capital resources on the development and commercialization of our pipeline of potentially transformative therapeutics for serious diseases."

-Pascal Touchon, President and CEO of Atara.

Atara anticipates having $371.1 million in cash, cash equivalents, and short-term investments as of December 31, 2021. This information is preliminary, has not been audited, and is subject to change upon the company's financial statements for the year ending December 31, 2021, being audited.

Atara will get USD 100 million upon closing, and Fujifilm intends to hire roughly 140 highly experienced manufacturing and quality personnel at the facility. In addition, the arrangement is projected to result in a multi-year reduction in Atara's planned operating expenses. Following the transaction's close, the upfront consideration, combined with the decrease in operating expenses, is expected to fund Atara's planned operations through Q4 2023, beyond the anticipated completion of the randomized, placebo-controlled Phase 2 study of ATA188, the company's investigational off-the-shelf T-cell candidate with the potential to reverse disability in progressive multiple sclerosis.

Atara retains the recently established Atara Research Center (ARC) in Thousand Oaks, California. The ARC is fully operational and will house Atara's Pre-Clinical, Translational Sciences, Manufacturing Process Sciences, and Analytical Development teams, enabling the company to accelerate innovation by using the company's unique and differentiated allogeneic cell therapy platform. Additionally, Atara will retain a competent technical operations staff to manage external production, quality, logistics, and supply chain management.

"We are thrilled that through this acquisition, we will add approximately 140 talented staff from Atara’s cell therapy manufacturing facility to the FUJIFILM Diosynth Biotechnologies family. The collective expertise of the team will further support our efforts as a world-class CDMO, We also look forward to adding the facility to FUJIFILM Diosynth Biotechnologies’ existing global footprint and to bolstering the expansion of our advanced therapies CDMO business."

-Martin Meeson, chief executive officer, FUJIFILM Diosynth Biotechnologies

ATOM is a 90,000-square-foot state-of-the-art T-cell therapy manufacturing facility that is fully qualified to support clinical and commercial production and is built to scale to meet various production requirements and capacities. The transaction is scheduled to close in April 2022, subject to the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act and other standard closing conditions.

Atara is advised by Evercore Group LLC on a strategic level and by Gibson Dunn & Crutcher LLP on a legal one.

*This press release contains or may contain "forward-looking statements," as defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.

Spotlight

A complete overview of Herman Miller.

Spotlight

A complete overview of Herman Miller.

Related News

MANUFACTURING TECHNOLOGY

Timken Completes Acquisition of GGB Bearings

The Timken Company | November 08, 2022

The Timken Company (NYSE: TKR; www.timken.com), a global leader in engineered bearings and industrial motion products, has completed its previously announced acquisition of GGB Bearings. Founded in 1899, GGB Bearings serves a variety of diverse customers, markets, geographies and applications with a product portfolio that complements existing Timken industry-leading engineered bearing solutions. GGB Bearings' revenue is expected to be around $200 million in fiscal year 2022. With manufacturing facilities across the United States, Europe and China, GGB Bearings employs approximately 900 people and has a global engineering, distribution and sales footprint. GGB Bearings is a global technology and market leader of premium engineered metal-polymer plain bearings with expertise in material science, surface engineering and tribology. Its tribology solutions in plain bearing coatings complement Timken's leading positions in roller and ball bearings. GGB Bearings' products are used mainly in industrial applications, including pumps and compressors, HVAC, off-highway, energy, material handling and aerospace. About The Timken Company: The Timken Company designs a growing portfolio of engineered bearings and industrial motion products. With more than a century of knowledge and innovation, we continuously improve the reliability and efficiency of global machinery and equipment to move the world forward. Timken posted $4.1 billion in sales in 2021 and employs more than 18,000 people globally, operating from 43 countries.

Read More

DI-Core Predictive Maintenance Software Selected by Major IDM

Cohu | December 13, 2022

Cohu, Inc. (NASDAQ: COHU), a global supplier of equipment and services optimizing semiconductor manufacturing yield and productivity, today announced that a major European IDM has selected and deployed Cohu’s Predictive Maintenance (PdM) software. PdM is part of a suite of data analytics software products sold under the DI-Core Data Intelligence System brand. The software is sold per handler based on an annual subscription. PdM software provides real-time component and thermal performance analytics that enables semiconductor manufacturers to significantly improve overall equipment efficiency for Cohu’s large installed base of handlers. By analyzing a broad range of internal handler sensor data, the software provides advance notice to perform proactive maintenance to minimize failures and increase equipment uptime. PdM extends Cohu’s handler automation capability for semiconductor manufacturers’ lights out automated factory and Industry 4.0 initiatives. Implementing predictive maintenance enables increased productivity by reducing downtime and increasing production output per machine. The market for predictive maintenance software as part of the global manufacturing industry is estimated at $1.0B and is projected to grow at 20% CAGR. “We are pleased to introduce our DI-Core PdM software and receive validation with an order from a major IDM, After extensive evaluation, the customer has deployed PdM on Cohu MATRiX handlers to enable automation and optimization of their test process. The software delivers comprehensive equipment data analytics to improve equipment productivity.” -Luis Müller, President and CEO Cohu. About Cohu: Cohu (NASDAQ: COHU) is a global technology leader supplying test, automation, inspection and metrology products and services to the semiconductor industry. Cohu’s differentiated and broad product portfolio enables optimized yield and productivity, accelerating customers’ manufacturing time-to-market.

Read More

DIGITAL TRANSFORMATION

Siemens Energy Selects Syntax for Global Implementation Partnership with SAP Digital Manufacturing Cloud

Siemens Energy | December 16, 2022

Syntax, the leading multi-cloud and multi-ERP managed cloud provider for mission-critical applications, today announced a partnership with Siemens Energy to design and implement its new SAP Digital Manufacturing Cloud (DMC) infrastructure for over 80 production sites globally. Syntax will execute the SAP DMC subscription contract for five pilot plants located in Germany, Mexico, and the United Kingdom. These sites reflect the enormously wide range of Siemens Energy’s requirements as Syntax gathers critical process data for analysis, process modeling and execution, and resource coordination. During this period, Syntax will also provide expertise in the integration of manufacturing processes for the company, creating a strong foundation for a digital factory implementation through the creation of a standard template. This Siemens Energy template, which is set to be developed before the end of 2023, will gradually be rolled out globally over a period of seven years. "We are very proud that Siemens Energy has chosen Syntax for this strategic and important global initiative, The combination of SAP know-how, industry experience and global positioning that Syntax brings to the table is unique – especially with the addition of our recently-founded global Center of Excellence for Manufacturing and participation in global certification programs.” -Ralf Sürken, CEO Europe, Syntax. As one of the world’s leading energy technology companies, Siemens Energy operates globally along nearly the entire energy value chain. Its products include gas turbines, steam turbines, generators, transformers, and compressors. Siemens Energy’s stake in Siemens Gamesa Renewable Energy makes it a global market leader in renewable energies including conventional and renewable energy technology, such as gas and steam turbines, hybrid power plants operated with hydrogen, and power generators and transformers. "We chose to partner with Syntax because of its holistic approach to digital transformation, and its high level of expertise and extensive experience with projects related to the SAP Digital Manufacturing Cloud, As an important part of our sustainable digitization strategy within the production areas, this project is of great strategic importance for Siemens Energy. Using the same systems at all production sites is the basis for notably better cooperation, protection against cybersecurity threats, and more efficient interests of the customer." -Matthias Hammes, IT project manager, Siemens Energy. With the many years of experience and proven multi-cloud expertise, Syntax understands industrial settings and knows how to implement customers’ best business solutions in appropriate SAP systems. As a global IT service provider, Syntax is increasingly aware and remains focused on supporting customers and partners with an eye on social and environmental impacts of the products and services they buy, build and use. About Syntax Syntax provides comprehensive technology solutions and trusted professional, advisory, and application management services to power businesses’ mission-critical applications in the cloud. With 50 years of experience and 700+ customers around the world, Syntax has deep expertise in implementing and managing multi-ERP deployments in secure private, public, or hybrid environments. Syntax partners with SAP, Oracle, JD Edwards, AWS, Microsoft, and other global technology leaders to ensure customers’ applications are seamless, secure, and at the forefront of enterprise technology innovation. About Siemens Energy Siemens Energy is one of the world's leading energy technology companies. The company works together with its customers and partners on the energy systems of the future, thereby supporting the transition to a more sustainable world. With its portfolio of products, solutions and services, Siemens Energy covers almost the entire energy value chain - from energy generation to energy transmission and storage. The portfolio includes conventional and renewable energy technology, such as gas and steam turbines, hydrogen-powered hybrid power plants, generators and transformers. More than 50 percent of the portfolio is already decarbonized. Through the majority stake in the listed Siemens Gamesa Renewable Energy (SGRE), Siemens Energy is one of the world market leaders in renewable energies. An estimated one sixth of the world's electricity generation is based on technologies from Siemens Energy. Siemens Energy employs around 92,000 people in more than 90 countries worldwide and generated sales of 29 billion euros in the 2022 fiscal year.

Read More